Bio-Gate Aktie
| 2,60EUR | 0,06EUR | 2,36% |
WKN DE: BGAG0J / ISIN: DE000BGAG0J3
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 4 | 4 | 3 | 2 | 3 |
| Summe Anlagevermögen | 2 | 2 | 2 | 2 | 2 |
| Summe Aktiva | 5 | 6 | 5 | 4 | 5 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 | 2 | 2 | 2 | 3 |
| Summe Eigenkapital | 4 | 4 | 3 | 2 | 2 |
| Summe Passiva | 5 | 6 | 5 | 4 | 5 |
Adresse
| Neumeyerstrasse 28-34, 90411 Nuremberg | |
| Telefon | +49 (911) 47-75-23-100 |
| Fax | +49 (911) 47-75-23-101 |
| Internet | http://www.bio-gate.de |
Management
|
Karl Richter
Chairman-Supervisory Board |
|
Marc Lloret-Grau
Chief Executive Officer |
|
Thomas Konradt
Director-Business Development |
|
Volker Alt
Member-Supervisory Board |
|
Volker Rofalski
Vice Chairman-Supervisory Board |